A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma.

Overview
Research
Identity
Additional Document Info
View All

authors

Mahalingam, Devalingam
Peguero, Julio
Cen, Putao
Arora, Sukeshi P
Sarantopoulos, John
Rowe, Julie
Allgood, Victoria
Tubb, Benjamin
Campos, Luis

publication date

January 1, 2019

published in

Cancers Journal